Rods handle vision in low light, cones take care of daylight and colour, and ‘rod-cone dystrophy’ is simply the label given to whichever group of cells gives way first. In this pattern specifically, the rods go first and cone involvement only joins in later — and that sequencing is exactly what places most textbook cases of retinitis pigmentosa inside this category. It carries real clinical weight because it predicts, with reasonable reliability, which visual functions fade earliest and which hold on longest.
For a Zimbabwean patient who arrives already carrying this exact term on a referral letter, understanding that rod-first order clears up a good deal of confusion from the very first conversation.
10+
years Experience
years Experience
5000+
Patients treated
Patients treated
100+
Countries served
Countries served
NABH
Guided facility
Guided facility
Ocular Symptoms
With rods failing first, night-time difficulty and a gradually narrowing visual field tend to dominate the early and middle stages, while central vision and colour perception generally hold steady across that same stretch — only starting to slip later, once cone involvement begins as well. Many patients describe it less as blurring and more as their surroundings gradually closing in from the sides inward.
Underlying Causes
The rod-first pattern traces back to mutations in genes that matter disproportionately to rod cell survival, which explains much of the genetic crossover with the wider RP category. Inheritance can follow a dominant, recessive, or X-linked route depending on the specific gene at fault, and the condition can appear in isolation or as one component of a broader syndrome touching other body systems.
Diagnosis for Ugandan Patients
Electroretinography carries most of the diagnostic weight in telling rod-cone dystrophy apart from its mirror-image counterpart, cone-rod dystrophy: here, the rod-driven signal comes back markedly weaker than the cone-driven one, particularly in earlier stages. Visual field testing maps the extent of peripheral loss, while OCT shows how much of the photoreceptor layer remains intact.
Meet The Team
Our Eye Specialists
Dr. Pawan
Associate Professor, Vitreo-Retina Surgeon. 10+ Years Experience
Retinal disorders, diabetic retinopathy, and advanced retina procedures. Provides diagnostic evaluation and treatment planning for international patients.
Dr.Pallavee
Senior Consultant Ophthalmologist & Eye Surgeon· 26+ yrs experience
Areas of Focus: Cataract surgery, corneal disorders, refractive procedures, and glaucoma management. Provides comprehensive eye care and surgical expertise for global patients.
Dr. Robin
Consultant Ophthalmologist & Eye Surgeon, MD, DO .16+ Years Experience
Areas of Focus: Cataract surgery, corneal disorders, refractive procedures, and glaucoma management. Provides comprehensive eye care and surgical expertise for global patients.
Treatment Approach in India
Care follows the same regenerative and supportive framework applied across the progressive dystrophies — stem cell therapy is assessed for patients whose results suggest they’re reasonable candidates, combined with practical guidance for adapting to reduced night and peripheral vision while central sight remains relatively stable for longer.
Reviews
What Our Patients Say
DR NAAGALAKSHMI R
1 week ago
Asha Babbar
2 weeks ago
The overall experience at the RP Treatment Center was very good. The staff was supportive and caring, and we provided proper attention and guidance during treatment. The environment at the center was clean and comfortable. The doctors and staff tried to understand patients' needs and explained the treatment process well.
Overall, I am satisfied with the service and care. Highly recommended!
Overall, I am satisfied with the service and care. Highly recommended!
Harshita Kapoor
2 weeks ago
Life‑Changing Experience with RP Therapy”
After years of struggling with vision loss due to Retinitis Pigmentosa, I finally found hope here. The doctors were highly professional, explained the stem cell treatment in detail, and gave me confidence at every step. The therapy was smooth, and I’ve already noticed positive changes in my daily life. Their dedication, care, and advanced medical approach make this center truly trustworthy
After years of struggling with vision loss due to Retinitis Pigmentosa, I finally found hope here. The doctors were highly professional, explained the stem cell treatment in detail, and gave me confidence at every step. The therapy was smooth, and I’ve already noticed positive changes in my daily life. Their dedication, care, and advanced medical approach make this center truly trustworthy
Yash Chauhan
2 weeks ago
I had a really good experience at RP Treatment Centre. The doctor listened to my problem patiently and explained the treatment in a simple way. The staff was polite and the clinic was clean. I started feeling better after the treatment. Highly recommended!
pragya chauhan
2 weeks ago
Very satisfied with the service. The doctor is experienced and gives proper attention to every patient. The staff is friendly, and the overall environment is comfortable. Thank you, RP Treatment Centre, for the excellent care.
Manisha kapoor
2 weeks ago
I had been struggling with Retinitis Pigmentosa for years, and finding this center was truly life‑changing. The doctors provided a thorough medical evaluation and explained every step of the stem cell therapy process with clarity. The treatment was smooth, professional, and I noticed encouraging improvements in my vision within weeks. Their continuous follow‑up care and compassionate support made me feel confident throughout the journey. Highly recommended for anyone seeking advanced RP treatment in India.
Frequently Asked Questions
Is rod-cone dystrophy basically another name for RP?
“There’s substantial overlap between the two. ‘Rod-cone dystrophy’ describes the order the disease follows — rods first, cones later — and that particular sequence applies to most cases that end up clinically labelled retinitis pigmentosa.”
What actually separates rod-cone from cone-rod dystrophy?
”
It comes down to which cell type fails first. Rod-cone dystrophy hits night and peripheral vision early while central and colour vision hold up longer; cone-rod dystrophy runs the opposite course, with central and colour vision affected sooner.”
Will my central vision eventually be affected too?
“In many rod-cone cases, eventually yes — central vision can decline once the disease progresses far enough to involve the cones, though how long that takes varies considerably from gene to gene and patient to patient.”
How often will I need monitoring visits?
“That’s decided case by case, based on how quickly ERG and field results shift after the initial assessment. Some patients need only annual review, while others with a faster-moving pattern are seen more often.”
